We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Lipoprotein Lipase Gene Linked to Insulin Resistance

By Biotechdaily staff writers
Posted on 23 Jan 2004
A recent study has found that insulin resistance, a syndrome closely linked to the development of diabetes and heart disease, is controlled by variations in the gene for lipoprotein lipase (LDP).

Investigators at Cedars-Sinai Hospital (Los Angeles, CA, USA) and the University of California, Los Angeles (USA), studied a large family-based population of Mexican Americans, a group with a higher-than-average incidence of insulin resistance. More...
The population comprised 291 adult offspring of parents with documented heart disease (112 men and 179 women). They were tested for glucose tolerance by the glucose clamp method, and the DNA profile of each individual was established. Eight different LDP haplotypes were found. Haplotypes are alternative forms of the genotype of a gene complex.

Results published in the January 2004 issue of Diabetes revealed that 40 patients carried haplotype 4, the gene marker linked to insulin resistance, while 239 carried haplotype 1, which was associated with a low level of insulin resistance.

"This is the first study to definitively show that LPL is a gene for common insulin resistance,” explained senior author Dr. Jerome I. Rotter, director of the division of medical genetics at Cedars-Sinai Medical Center. "Our study showed that two separate haplotypes of LPL were linked to low or high levels of insulin resistance, confirming that the LPL gene plays a role in determining insulin resistance in this population of Mexican Americans.”




Related Links:
Cedars-Sinai Hospital
University of California, Los Angeles

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Prefilled Tubes
Prefilled 5.0ml Tubes
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.